Company / Working Capital
Praxis Precision Medicines, Inc. Working Capital History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Working Capital
$551.1M
FY2025
5-year range
$69.1M / $551.1M
FY2021-FY2025
Trend
+50.2%
vs FY2024
Sector context
#82 of 213
Health Care
What the data says
At $551M, Praxis Precision Medicines, Inc.'s working capital ranks #82 of 213 in the Health Care sector. Improved from $69M to $551M over the past 2 years.
Based on SEC 10-K filings.
$551M in FY2025 with a 5-year CAGR of +14.0%.
Improved from $69M to $551M over the past 2 years.
Health Care sector context is included.
Working Capital over time
Growth rates
- 3-Year CAGR
- +93.1%
- 5-Year CAGR
- +14.0%
- 10-Year CAGR
- -
Sector benchmark
#82 of 213 in Health CareTop 38% of 213This company $551.1M Sector average $934.6M
▼
-41.0% below sector average
Key checks
Key Insights
- 5-year CAGR of +14.0%, indicating consistent growth.
- In FY2025, working capital increased 50.2% year-over-year.
- Ranks #82 out of 213 companies in the Health Care sector.
- Lowest working capital in the period was in FY2019.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 4.48 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Working CapitalValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $551.1M | +50.2% |
| FY2024 | $366.8M | +430.6% |
| FY2023 | $69.1M | -9.6% |
| FY2022 | $76.5M | -69.3% |
| FY2021 | $249.0M | -13.1% |
| FY2020 | $286.6M | +641.0% |
| FY2019 | $38.7M | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026